Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)

Market Cap	5.41B
Revenue (ttm)	527.38M
Net Income (ttm)	32.46M
Shares Out	23.85M
EPS (ttm)	1.36
PE Ratio	166.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	660,620
Average Volume	1,623,488
Open	233.40
Previous Close	236.00
Day's Range	231.50 - 238.40
52-Week Range	76.00 - 259.50
Beta	0.99
RSI	56.64
Earnings Date	Nov 3, 2025

About IST:ONCSM

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins, infectious waste and toxic laboratory waste; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 292
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ONCSM

Financial Performance

In 2024, IST:ONCSM's revenue was 374.49 million, an increase of 7.85% compared to the previous year's 347.24 million. Losses were -59.17 million, -48.65% less than in 2023.